经皮穴位电刺激治疗1级高血压:随机对照预试验方案
TEAS组在家接受四肢四个穴位非侵入性电刺激,每次30分钟,每周4次,共12周48次;对照组不接受任何穴位刺激。两组均接受生活方式教育。主要结局为12周平均收缩压较基线变化。
要点
- TEAS组每周4次、每次30分钟、共12周48次家庭电刺激。
- 主要结局为12周平均收缩压较基线变化。
- 预试验为后续大样本随机对照试验提供样本量依据。
核心结论
- 该预试验将探索TEAS治疗1级高血压的可行性,并为疗效和安全性提供潜在临床证据。
关键数值与推荐
- TEAS组在四肢四个穴位接受非侵入性电刺激,每次30分钟,每周4次,持续12周,共48次。
- 对照组不接受任何形式的穴位刺激,两组均接受饮食、体重控制和运动等生活方式教育。
- 主要结局指标为基线至12周平均收缩压的变化。
- 次要结局包括平均舒张压变化、生活质量、体重指数和体力活动水平。
局限性
- 作为预试验,研究目的在于探索可行性和为后续大样本试验提供样本量依据,尚不能提供确证性疗效结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypertension is a major pathogenic factor of cardiovascular diseases. Insufficient blood pressure control rate and sub-optimal medication adherence remain challenges for effective management of hypertension. Transcutaneous electrical acupoint stimulation (TEAS) has been used to treat various diseases, including hypertension, but the scientific evidence for its benefit remains insufficient. Therefore, we will perform a randomized, controlled clinical trial in patients with stage 1 hypertension to evaluate the effect of TEAS. METHODS/DESIGN: The study will be a two-arm parallel, randomized controlled trial. Sixty patients with stage 1 hypertension will be randomly assigned to the TEAS group and the control group in a 1:1 ratio. The participants in the TEAS group will receive non-invasive acupoint electrical stimulation for 30 min at four acupoints in the upper and lower extremities at home, 4 times weekly for 12 weeks for a total of 48 sessions. Participants in the control group will not receive any form of acupoint stimulation. All participants in both groups will receive lifestyle education on how to control high blood pressure, including diet, weight control, and exercise. The primary outcome measure will be the change of the mean systolic blood pressure from baseline to 12 weeks. Secondary outcomes include the change of mean diastolic blood pressure, quality of life, body mass index, and physical activity level. DISCUSSION: This pilot, randomized, controlled trial will explore the feasibility of TEAS. It will also provide potential clinical evidence for the efficacy and safety of TEAS in the treatment of patients with stage 1 hypertension. The results of this study will be published in peer-reviewed journals. Furthermore, this pilot trial as the precursor of a large scale randomized controlled trial will inform the sample size of the subsequent trial. TRIAL REGISTRATION: Chinese clinical trial registry, ChiCTR1900025042, Registered on 8 August 2019 (http://www.chictr.org.cn/showproj.aspx?proj=41496).
引用
- Tian ZX, Liu CZ, Qi YS, et al. Transcutaneous electrical acupoint stimulation for stage 1 hypertension: protocol for a randomized controlled pilot trial. Trials. 2020. PMID: 32571411. doi:10.1186/s13063-020-04493-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。